The Weekly Roundup: PBM pricing practices (1.25.19)
This week, Stat News shared coverage of the “unchecked PBM industry” that is currently under scrutiny in New York by pharmacists concerned about spread pricing in the state’s Medicaid program. A Bloomberg analysis of the practice using Medicaid data reviewed the most common generics and found markups of approximately 32 percent. Of course, the practice is nothing new, but scrutiny seems to be on the rise, and some two dozen states passed attempts to weed out opaque pricing practices during the last legislative session. CVS was recently slapped for the practice when an audit in Ohio found that Ohio PBMs billed managed care payers $223 million more in 2017 than what they paid in pharmacy costs, prompting the state to move to a pass-through model.
Here are a few other stories that might be of interest:
- There is optimism despite decline among independent pharmacies—particularly for those with multiple locations.
- Another study finds pharmacist intervention is key to preventing or reducing readmissions.
- No new drugs? FDA running on dwindling user-fee funding during government shutdown as agency “prioritizes approvals that impact the public safety,” according to FDA Commissioner Dr. Scott Gottlieb.
- The lines have been drawn—again. Physician and patient advocacy groups lining up to battle proposed changes to CMS drug pricing approach in the court of public opinion.
- Put your money where your mouth is. Children’s Hospital in Pennsylvania opens “food pharmacy” to encourage better nutrition.
[Editor’s note:] Our inboxes are stuffed with newsletters and our coffee tables stacked with magazines and industry digests. I’m sure yours are, too. So, we’ve decided to run a weekly sampling of interesting stories, issues coverage, and business ideas we come across each week. We hope you’ll share some of your favorites, too. Drop us a line at email@example.com.
Sign up now to receive the latest independent
pharmacy news, tips, and resources.
From blood to sweat and tears, smart technology is changing the way diabetes is monitored and treated. Last spring, a continuous glucose monitor (CGM) that attached to the abdomen was the first of its kind approved by the FDA. Last summer,...
With a reach of 32 million lives, Accountable Care Organizations are good testing grounds for new concepts and programs to improve the quality and delivery of healthcare. More and more, those organizations are relying on pharmacists to help them deliver results. Physicians are recognizing&...